Drug Development Global Program

Fulfilling the promise of medicine for the developing world

PATH’s Drug Development Global Program grew from our affiliation in late 2011 with the nonprofit drug development group OneWorld Health. We’re working to discover, develop, and deliver safe, effective, and affordable new treatments for diseases disproportionately affecting people in the developing world. By combining entrepreneurial energy, pharmaceutical expertise, and an innovative product development partnership model, we challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs.

Our approach is simple. Assemble an experienced and dedicated team. Identify the most promising drug candidates. Develop them into safe, effective, and affordable medicines. Then collaborate with companies to manufacture and distribute newly approved therapies that will affect the health of millions.

By partnering and collaborating with industry and researchers, securing donated intellectual property and finding new uses for orphan drugs, and harnessing the scientific and manufacturing capacity of both developed and developing countries, we can deliver safe, effective, and affordable new medicines where they are needed most.

Read more about our efforts to develop safe, effective, and affordable drugs on the OneWorld Health website.

Banner photo: Jonathan Torgovnik.

Comments are closed.